1 |
Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications[J]. Cell Res, 2021, 31(2): 107-125.
|
2 |
Liu J, Song X, Kuang F, et al. NUPR1 is a critical repressor of ferroptosis[J]. Nat Commun, 2021, 12(1): 647.
|
3 |
Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156(1-2): 317-331.
|
4 |
Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072.
|
5 |
Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis[J]. Nat Chem Biol, 2017, 13(1): 81-90.
|
6 |
Yuan H, Li X, Zhang X, et al. Identification of ACSL4 as a biomarker and contributor of ferroptosis[J]. Biochem Biophys Res Commun, 2016, 478(3): 1338-1343.
|
7 |
Macías-Rodríguez RU, Inzaugarat ME, Ruiz-Margáin A, et al. Reclassifying hepatic cell death during liver damage: ferroptosis-A novel form of non-apoptotic cell death?[J]. Int J Mol Sci, 2020, 21(5): 1651.
|
8 |
Gao W, Zhao J, Gao Z, et al. Synergistic interaction of light alcohol administration in the presence of mild iron overload in a mouse model of liver injury: involvement of triosephosphate isomerase nitration and inactivation[J]. PLoS One, 2017, 12(1): e0170350.
|
9 |
Liu CY, Wang M, Yu HM, et al. Ferroptosis is involved in alcohol-induced cell death in vivo and in vitro[J]. Biosci Biotechnol Biochem, 2020, 84(8): 1621-1628.
|
10 |
Tsurusaki S, Tsuchiya Y, Koumura T, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis[J]. Cell Death Dis, 2019, 10(6): 449.
|
11 |
贺明, 魏倩, 张颖婷. 铁死亡相关机制与其在肝脏相关疾病中作用的研究进展[J]. 上海交通大学学报(医学版), 2020, 40(11): 1519-1523.
|
12 |
Wang H, An P, Xie E, et al. Characterization of ferroptosis in murine models of hemochromatosis[J]. Hepatology, 2017, 66(2): 449-465.
|
13 |
Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy[J]. Proc Natl Acad Sci USA, 2019, 116(7): 2672-2680.
|
14 |
Wu C, Zhao W, Yu J, et al. Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells[J]. Sci Rep, 2018, 8(1): 574.
|
15 |
Li G, Yang J, Zhao G, et al. Dysregulation of ferroptosis may involve in the development of non-small-cell lung cancer in Xuanwei area[J]. J Cell Mol Med, 2021, 25(6): 2872-2884.
|
16 |
di Masi A, De Simone G, Ciaccio C, et al. Haptoglobin: from hemoglobin scavenging to human health[J]. Mol Aspects Med, 2020, 73: 100851.
|
17 |
Shu H, Zhang S, Kang X, et al. Protein expression and fucosylated glycans of the serum haptoglobin-β subunit in hepatitis B virus-based liver diseases[J]. Acta Biochim Biophys Sin (Shanghai), 2011, 43(7): 528-534.
|
18 |
Outten FW, Theil EC. Iron-based redox switches in biology[J]. Antioxid Redox Signal, 2009, 11(5): 1029-1046.
|
19 |
Wang Y, Liu Y, Liu J, et al. NEDD4L-mediated LTF protein degradation limits ferroptosis[J]. Biochem Biophys Res Commun, 2020, 531(4): 581-587.
|
20 |
Yuan H, Li X, Zhang X, et al. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation[J]. Biochem Biophys Res Commun, 2016, 478(2): 838-844.
|
21 |
Alvarez SW, Sviderskiy VO, Terzi EM, et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis[J]. Nature, 2017, 551(7682): 639-643.
|
22 |
Gao M, Monian P, Pan Q, et al. Ferroptosis is an autophagic cell death process[J]. Cell Res, 2016, 26(9): 1021-1032.
|
23 |
Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J]. Nat Chem Biol, 2017, 13(1): 91-98.
|
24 |
Lei G, Zhang Y, Koppula P, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression[J]. Cell Res, 2020, 30(2): 146-162.
|
25 |
Yu Y, Jiang L, Wang H, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis[J]. Blood, 2020, 136(6): 726-739.
|
26 |
Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer[J]. J Hematol Oncol, 2019, 12(1): 34.
|
27 |
Gnanapradeepan K, Basu S, Barnoud T, et al. The p53 tumor suppressor in the control of metabolism and ferroptosis[J]. Front Endocrinol (Lausanne), 2018, 9: 124.
|
28 |
Qiu Y, Cao Y, Cao W, et al. The application of ferroptosis in diseases[J]. Pharmacol Res, 2020, 159: 104919.
|
29 |
Sreekanth GP, Chuncharunee A, Sirimontaporn A, et al. Role of ERK1/2 signaling in dengue virus-induced liver injury[J]. Virus Res, 2014, 188: 15-26.
|
30 |
Long T, Wang L, Yang Y, et al. Protective effects of trans-2,3,5,4'-tetrahydroxystilbene 2-O-β-D-glucopyranoside on liver fibrosis and renal injury induced by CCl4via down-regulating p-ERK1/2 and p-Smad1/2[J]. Food Funct, 2019, 10(8): 5115-5123.
|
31 |
Sampey BP, Stewart BJ, Petersen DR. Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal[J]. J Biol Chem, 2007, 282(3): 1925-1937.
|
32 |
Thakur V, Pritchard MT, McMullen MR, et al. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-α production[J]. J Leukoc Biol, 2006, 79(6): 1348-1356.
|
33 |
Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation[J]. J Hepatol, 2009, 50(6): 1258-1266.
|
34 |
Wang Z, Yao T, Song Z. Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease[J]. J Lipid Res, 2010, 51(11): 3158-3165.
|
35 |
Dong J, Viswanathan S, Adami E, et al. Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH[J]. Nat Commun, 2021, 12(1): 66.
|